Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details) - Schedule of Warrant Activities

v3.24.1
Shareholders' Deficit (Details) - Schedule of Warrant Activities - Warrant [Member] - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Shareholders' Deficit (Details) - Schedule of Warrant Activities [Line Items]
Number of Options, Balance Outstanding, Beginning (in Shares) 17,500,000
Weighted Average Exercise Price, Balance Outstanding, Beginning $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning 4 years 8 months 1 day
Aggregate Intrinsic Value, Balance Outstanding, Beginning
Warrant [Member]
Shareholders' Deficit (Details) - Schedule of Warrant Activities [Line Items]
Number of Options, Balance Outstanding, Beginning (in Shares) 34,000,000
Weighted Average Exercise Price, Balance Outstanding, Beginning $ 0.011
Aggregate Intrinsic Value, Balance Outstanding, Beginning
Number of Options, Granted (in Shares) 33,000,000
Weighted Average Exercise Price, Granted $ 0.025
Weighted Average Remaining Contractual Term (Years), Granted
Aggregate Intrinsic Value, Granted
Number of Options, Cancelled (in Shares) (16,500,000)
Weighted Average Exercise Price, Cancelled $ (0.05)
Weighted Average Remaining Contractual Term (Years), Cancelled
Aggregate Intrinsic Value, Cancelled
Number of Options, Balance Outstanding, Ending (in Shares) 34,000,000 34,000,000
Weighted Average Exercise Price, Balance Outstanding, Ending $ 0.011 $ 0.011
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 2 years 8 months 23 days 3 years 8 months 23 days
Aggregate Intrinsic Value, Balance Outstanding, Ending
Number of Options, Exercisable (in Shares) 34,000,000
Weighted Average Exercise Price, Exercisable $ 0.011
Weighted Average Remaining Contractual Term (Years), Exercisable 2 years 8 months 23 days
Aggregate Intrinsic Value, Exercisable